Literature DB >> 15774412

Perceptions of health risk susceptibility in methadone maintained smokers.

Jumi Hayaki1, Bradley J Anderson, Michael D Stein.   

Abstract

Despite the well-established health hazards associated with cigarette smoking, research indicates that many smokers underestimate their personal susceptibility to these health risks. Previous studies have examined this discrepancy, but validation of measures is lacking. The purpose of this investigation was to develop and validate a measure of smokers' perceptions of their own smoking-related health consequences. The Smokers' Perceived Health Risk Evaluation (SPHERE) was administered at baseline to 255 smokers recruited for a cessation trial at two methadone maintenance treatment programs in Providence, Rhode Island. The scale consisted of two 3-item subscales each demonstrating good to excellent internal consistency reliability: Smoking-Related Health (alpha = .66) and Smoking-Related Risk (alpha = .87). The subscales correlated with common smoking-related pulmonary symptoms, previous treatment for smoking-related illnesses, the physical health functioning scale of the SF-12, and participants' perceived importance of a cessation intervention. The SPHERE is a reliable instrument that captures unique dimensions of smokers' health expectancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774412     DOI: 10.1300/J069v24n01_07

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  9 in total

1.  Factor Structure and Stability of Smoking-Related Health Beliefs in the National Lung Screening Trial.

Authors:  Annette R Kaufman; Amber R Koblitz; Alexander Persoskie; Rebecca A Ferrer; William M P Klein; Laura A Dwyer; Elyse R Park
Journal:  Nicotine Tob Res       Date:  2015-05-10       Impact factor: 4.244

2.  An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.

Authors:  Michael D Stein; Celeste Caviness; Kristin Grimone; Daniel Audet; Bradley J Anderson; Genie L Bailey
Journal:  Nicotine Tob Res       Date:  2015-12-28       Impact factor: 4.244

3.  Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.

Authors:  M D Stein; C M Caviness; M E Kurth; D Audet; J Olson; B J Anderson
Journal:  Drug Alcohol Depend       Date:  2013-08-14       Impact factor: 4.492

4.  Effects of readiness to change, quit history, and health perceptions on depressive symptoms among young adult smokers.

Authors:  Dawn W Foster; Georges E Khalil; Samantha G Farris; Till W Bärnighausen; Alexander V Prokhorov
Journal:  Int J Psychol Psychoanal       Date:  2015-02-21

5.  Respiratory symptom relief related to reduction in cigarette use.

Authors:  Michael D Stein; Marjorie C Weinstock; Debra S Herman; Bradley J Anderson
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

6.  Research on older people's health information search behavior based on risk perception in social networks-A case study in China during COVID-19.

Authors:  Chi Zhang; Wei Fang Liao; Yi Ming Ma; Chang Yong Liang
Journal:  Front Public Health       Date:  2022-08-10

7.  Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education.

Authors:  Joseph Finkelstein; Oleg Lapshin; Eunme Cha
Journal:  J Med Internet Res       Date:  2008-11-03       Impact factor: 5.428

8.  The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients.

Authors:  Victoria Wapf; Michael Schaub; Beat Klaeusler; Lukas Boesch; Rudolf Stohler; Dominique Eich
Journal:  Harm Reduct J       Date:  2008-03-18

9.  Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study.

Authors:  Piyali Mandal; Raka Jain; Sonali Jhanjee; V Sreenivas
Journal:  Indian J Psychol Med       Date:  2015 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.